Sektor Perspective Therapeutics, Inc.

Aktien

A40EDR

US46489V3024

CATX

Biotechnologie

Markt geschlossen - 22:00:00 17.08.2026 % 5 Tage Veränd. 1. Jan.
3.220 USD +0.62% Intraday Chart für Perspective Therapeutics, Inc. +7.33% +17.09%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
+0.62%+7.33%+7.69%-16.36%+17.09%-10.80%-16.62%-47.20%-54.35% 368 Mio.
-0.35%-1.56%+0.25%+20.95%+5.32%+1.91%+20.03%-24.74%+204.03% 48.84 Mrd.
+4.07%+2.43%+13.88%+45.54%+166.16%+483.70%+623.80%+700.60% - 45.44 Mrd.
+4.33%+0.98%+16.18%+23.61%+19.32%+12.80%+88.53%+28.76%+1’184.59% 41.22 Mrd.
+1.94%-0.31%+16.96%+42.64%+7.02%+26.24%+12.62%-6.15%+220.37% 39.71 Mrd.
-0.50%0.00%+14.33%+11.78%+16.60%+20.60%+60.49%-10.77%+151.13% 32.6 Mrd.
+0.10%-3.22%-5.21%+2.87% - - - - - 16.25 Mrd.
+3.22%-0.88%+11.04%+43.79%+6.32%+30.42%+135.47%+232.75%+2’021.96% 16.67 Mrd.
-0.69%-0.54%-2.22%+15.71%+11.41%+3.24%+28.88%-40.72%+87.89% 14.08 Mrd.
+2.35%+3.48%+27.76%+90.02%+43.69%+82.95%+43.41%-31.34%+245.68% 13.68 Mrd.
+3.86%+2.05%-0.32%+45.60%-7.01%-3.63%-32.76%-29.91%+123.73% 13.07 Mrd.
+2.02%+6.55%+41.23%+88.45%+76.26%+65.76%+77.19%-37.60% - 12.37 Mrd.
-0.01%+0.37%+0.37%+67.18%+23.09%+35.06%-9.78%-38.91%+158.19% 11.28 Mrd.
-1.61%-5.09%-11.60%+9.21%-13.29%+74.87%+510.53%+294.71%+2’385.71% 10.57 Mrd.
+2.61%+2.57%+19.71%+9.87%+27.70%+699.45%+1’772.54%+61.36% - 10.51 Mrd.
+0.03%-0.04%+0.44%+65.87%+78.31%+260.93%+470.30% - - 10.15 Mrd.
+2.27%+5.75%+12.57%+55.24%+81.61%+182.90%+745.97%+228.54%+1’251.11% 10.26 Mrd.
+3.42%+11.82%+4.87%+47.68%+56.03%+184.80%+541.70%+132.81% - 10.1 Mrd.
+2.43%+2.97%+7.80%-21.02%-25.89%+33.92%+49.83%+51.26%+70.73% 9.74 Mrd.
-0.68%-6.21%-1.58%+17.55%-12.55%-30.01% - - - 9.32 Mrd.
Durchschnitt +1.39%+1.37%+8.71%+33.31%+30.38%+113.43%+284.56%+86.09%+619.29% 18.81 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung +1.68%+0.62%+9.94%+33.73%+37.19%+115.96%+232.48%+119.61%+583.38%
  1. Börse
  2. Aktien
  3. A40EDR Aktie
  4. Sektor Perspective Therapeutics, Inc.